CEP76 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.627000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.092200E-01
Normal-vs-Stage2
8.842600E-01
Normal-vs-Stage3
1.538480E-02
Normal-vs-Stage4
9.465200E-01
Stage1-vs-Stage2
8.244000E-01
Stage1-vs-Stage3
1.364420E-01
Stage1-vs-Stage4
7.595600E-01
Stage2-vs-Stage3
6.034700E-04
Stage2-vs-Stage4
7.978600E-01
Stage3-vs-Stage4
1.286630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.834200E-01
Normal-vs-AfricanAmerican
9.298400E-01
Normal-vs-Asian
3.621200E-01
Caucasian-vs-AfricanAmerican
9.091000E-01
Caucasian-vs-Asian
1.159990E-01
AfricanAmerican-vs-Asian
2.403600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.642200E-01
Normal-vs-Female
9.618000E-01
Male-vs-Female
4.882200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.915200E-01
Normal-vs-Age(41-60Yrs)
6.831000E-01
Normal-vs-Age(61-80Yrs)
8.693800E-01
Normal-vs-Age(81-100Yrs)
6.085000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.153400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.980800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.749000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.442100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.524200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.020200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.060800E-01
Normal-vs-Daily Drinker
4.799600E-01
Normal-vs-Weekly Drinker
5.866600E-01
Normal-vs-Occasional Drinker
7.807800E-01
Normal-vs-Social Drinker
6.135000E-01
Non Drinker-vs-Daily Drinker
9.458600E-01
Non Drinker-vs-Weekly Drinker
5.467200E-01
Non Drinker-vs-Occasional Drinker
2.271000E-01
Non Drinker-vs-Social Drinker
5.168200E-02
Daily Drinker-vs-Weekly Drinker
5.780200E-01
Daily Drinker-vs-Occasional Drinker
2.262000E-01
Daily Drinker-vs-Social Drinker
3.744300E-02
Weekly Drinker-vs-Occasional Drinker
3.200800E-01
Weekly Drinker-vs-Social Drinker
1.174020E-01
Occasional Drinker-vs-Social Drinker
9.593400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.965200E-01
Normal-vs-Grade 2
8.664800E-01
Normal-vs-Grade 3
4.403400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.796800E-01
Grade 1-vs-Grade 3
8.782200E-01
Grade 1-vs-Grade 4
6.965200E-01
Grade 2-vs-Grade 3
7.241800E-02
Grade 2-vs-Grade 4
8.664800E-01
Grade 3-vs-Grade 4
4.403400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.486800E-01
Normal-vs-NonDiabetic
9.697800E-01
Diabetic-vs-NonDiabetic
2.895800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.006400E-01
Normal-vs-NoPancreatitis
9.361400E-01
Pancreatitis-vs-NoPancreatitis
8.616400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.273000E-01
Normal-vs-N1
7.801600E-01
N0-vs-N1
1.948380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.343000E-01
Normal-vs-TP53-NonMutant
7.874000E-01
TP53-Mutant-vs-TP53-NonMutant
8.524400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
